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Abstract 
Clostridium difficile is a major cause of antibiotic induced diarrhoea worldwide, 
responsible for significant annual mortalities and represents a considerable economic 
burden on healthcare systems. The two main C. difficile virulence factors are toxins A and 
B. Isogenic toxin B mutants of two independently isolated erythromycin-sensitive 
derivatives (630E and 630Δerm) of strain 630 were previously shown to exhibit 
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substantively different phenotypes.  Compared to 630, strain 630E and its progeny grow 
slower, achieve lower final cell densities, exhibit a reduced capacity for spore-formation, 
produce lower levels of toxin and are less virulent in the hamster infection model. By the 
same measures, strain 630Δerm and its derivatives more closely mirror the behaviour of 
630. Genome sequencing revealed that 630Δerm had acquired seven unique Single 
Nucleotide Polymorphisms (SNPs) compared to 630 and 630E, while 630E had nine SNPs 
and a DNA inversion not found in the other two strains.  The relatively large number of 
mutations meant that the identification of those responsible for the altered properties of 
630E was not possible, despite the restoration of three mutations to wildtype by allelic 
exchange and comparative RNAseq analysis of all three strains. The latter analysis revealed 
large differences in gene expression between the three strains, explaining in part why no 
single SNP could restore the phenotypic differences. Our findings suggest that strain 
630∆erm should be favoured over 630E as a surrogate for 630 in genetic-based studies.  
They also underline the importance of effective strain curation and the need to genome re-
sequence master seed banks wherever possible.   
Keywords 
single nucleotide polymorphism; sporulation; motility; toxin expression; mutation; 
ClosTron; virulence 
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Introduction 
Clostridium difficile is a Gram-positive, anaerobic spore-forming bacterium capable of 
causing a range of diseases from mild diarrhoea to potentially fatal toxic 
pseudomembranous colitis. The toxigenic effects of C. difficile are caused by the activities 
of two large, glucosylating toxins. The two toxins are 308kDa (toxin A) and 270kDa (toxin B) 
in size 1-3 and are encoded by the chromosomally located genes tcdA and tcdB, 
respectively. Both are cytopathic to cultured cells due to disruption of the cytoskeleton, 
although TcdB is thought to be up to 1000-times more potent.1 Historically, toxin A was 
regarded as the main causative agent of the symptoms of C. difficile infection (CDI). Pivotal 
data was provided by Lyerly et al.4 who were only able to detect disease when hamsters 
were subject to intragastric challenge with purified TcdA alone and not with TcdB. The 
latter could, however, cause disease symptoms if prior damage to the mucosa had been 
inflicted by co-administration of sub-lethal concentrations of toxin A. Furthermore, co-
administration of both toxins led to more severe disease symptoms. To accommodate 
these data, it was generally accepted that both toxins acted in concert to bring about 
disease symptoms, with toxin A leading to the initial damage to the colon allowing the 
subsequent access of the more potent toxin B. 
During the 1990’s C. difficile strains were isolated from symptomatic patients that only 
produced toxin B (A-B+)5, 6. These findings suggested that toxin B, at least in certain strains, 
is capable of causing disease without the help of toxin A. It has been reported since that 
toxin B, in A-B+ strains, is modified and seems to be an evolutionary hybrid of C. difficile 
toxin B and Clostridium sordellii lethal toxin.7 
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With the development of genetic systems, assumptions of the relative importance of 
the two toxins could be tested through the creation, and in vivo assay, of isogenic mutants 
in which production of either toxin had been ablated. Initial findings made by Lyras et al.8 
appeared to turn the perceived view on its head, through the demonstration that a tcdA 
mutant producing TcdB alone (A-B+) was capable of causing disease in the hamster model 
while a tcdB mutant producing only TcdA (A+B-) did not.  These data were, however, 
almost immediately questioned by a second study conducted in the Minton laboratory 9 
showing that both tcdA and tcdB C. difficile mutants, and therefore TcdA and TcdB alone, 
were independently capable of causing disease. Interestingly, a strain has recently10 beren 
isolated from a clinical case of CDI, that only produces TcdA (A+B-) 
The possible reasons for the observed difference in outcomes of the two studies have 
been discussed previously. 11 Both studies agree on the virulence potential of toxin B, but 
uncertainties remain about the different outcomes concerning the effects of toxin A. In the 
work presented here, we have hence focused on comparisons of the parental strains and 
the strains only producing toxin A (A+B-). In essence, both sets of mutants were generated 
by insertional inactivation of the toxin genes of the C. difficile strain 630 12 and, once 
created, were tested in the hamster infection model. However, in order to implement the 
available gene tools in strain 630 (at the time the only strain for which a genome sequence 
was available), it was necessary to first isolate a variant that had become sensitive to 
erythromycin, thereby allowing the use of an ermB gene as a selective, genetic marker. 
Both studies used such an erythromycin-sensitive derivative of strain 630, but they were 
independently isolated.  In our study (Minton group), 9 we used the strain 630Δerm, 
isolated in the Mullany laboratory (UCL, London, UK) after 30 repeated subcultures of 
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strain 630 in non-selective media. 13 In parallel, the Rood laboratory (Monash, Australia) 
independently isolated the erythromycin sensitive strain JIR8094 (also referred to as 630E), 
14 through an undisclosed number of subcultures of strain 630 in non-selective media. Both 
strains are reported to possess the same specific deletion of ermB. 13, 14 
We have previously hypothesised 11 that the different outcomes of the two studies 8, 9 
are a direct consequence of the use of the two, independently isolated erythromycin-
sensitive strains, 630Δerm and 630E. We suggested that during repeated subculture, 
ancillary mutations arose which impacted on the virulence potential of one or other of the 
two strains in the presence of different toxin gene alleles. In the current piece of work, we 
have set out to test this hypothesis. We have undertaken side-by-side comparisons of 
630Δerm and 630E, and the A+B- mutant derivatives, in a variety of assays to establish 
phenotypic differences. In parallel, we have determined the genome sequences of the 
various strains used in the two studies. 8, 9 Then, we have used our newly developed allelic 
exchange methodologies 15 to correct a number of SNPs in strain 630E back to wild-type 
and assessed the consequences. Furthermore we have performed RNAseq experiments 
comparing the transcriptome of 630, 630Δerm and 630E at three different time points. The 
RNA data were related to the whole genome data to draw our final conclusions. 
Results 
Generation of a ClosTron insertion in tcdB of 630E 
Although considered unlikely, the possibility existed that mutants made by the 
insertion of a plasmid element carrying ermB 14 might behave differently to an equivalent 
mutant made by the insertion of a group II intron incorporating ermB. 16 Our initial step 
was, therefore, to create a tcdB mutant of strain 630E using ClosTron technology. 
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Accordingly, the ClosTron plasmid pMTL007C-E2::Cdi-tcdB-1511a that had previously been 
used to generate strain 630∆erm A+B- 9 was used to create an equivalent mutant in strain 
630E as described. 9 The resulting mutant, 630E A+B-CT, was verified by PCR, Sanger 
sequencing and shown by Southern blot to carry a single group II intron insertion (Fig. 
S1A). Parental strains, original A+B- mutants and the newly obtained mutant were tested 
for production of toxin A in a Western blot (Fig. S1B). As expected all strains produced 
toxin A. 
Phenotypic characterisation of strains 
In order to establish whether all strains were phenotypically identical a range of assays 
were performed, comparing growth, motility and spore properties. An analysis of growth 
rates using the procedure described in Materials and Methods showed that strain 630∆erm 
and derivatives grew to the highest optical density, closely followed by strain 630 and 
630E, and derivatives thereof (Fig. 1A and 1B). The data clearly demonstrated that strain 
630∆erm and its 630∆erm A+B- derivative had relatively higher growth rates and achieved 
higher optical densities (p < 0.0001, unpaired t-test at 24 h) than strain 630E and its 
derivatives, with strain 630E A+B-CT growing the least (Fig. 1B). It was also apparent, 
shown by plate motility assay (Fig. 2), that strains 630 and 630∆erm were motile, while 
630E was not. Only 630 and 630∆erm, but not 630E, form pseudopod-like structures, 
which are characteristic for swarming motility in bacteria.   
Following the protocols of Burns et al, 17 comparative differences in the numbers of 
colony forming units (CFUs) obtained following heat shock were assessed between the 
strains, as a crude estimate of spore formation. 18 On this basis, strains 630∆erm and 
630∆erm A+B- produced a greater numbers of spores than 630E and its derivatives, which 
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failed to produce any spores until 72 h. The total number of CFU/mL at this time point was 
103 times fewer than that obtained with 630∆erm or 630∆erm A+B- (Fig. 3A). Interestingly 
parental strain 630 produced very few spores before 72 h, but spore counts increased from 
72 h onwards and reached similar levels to strains 630∆erm and 630∆erm A+B- by the end 
of the experiment. The reduction in spore formation may in part be due to the observed 
reduction in OD as the 630E strains enter stationary phase, which might also explain their 
predilection to flocculate. Indeed comparing percentage sporulation (relative to vegetative 
cell count), confirmed the observation that 630∆erm and 630∆erm A+B- have a higher 
sporulation frequency than both 630E (and derivatives) and strain 630. 
The germination of the 630E strains was also comparatively reduced and did not reach 
the same level as that of 630∆erm and its progeny. At the last time point (240 min) strains 
630E and 630E A+B- reach the same level of CFU/ml as strain 630. The observed delay 
could be due to the previously observed reduced cell growth of the 630E strains (Fig. 3B).   
Toxin Production  
Measurements of the amounts of toxin being produced by 630E and 630∆erm and 
their derivatives were undertaken using both the C. DIFFICILE TOX A/B II™ ELISA assay kit 
from TechLab, measuring toxin A and B, and kits from TGCbiomics, specifically measuring 
either only toxin A or only toxin B. The results of the 72 h time point are shown in Fig. 4.  
As shown in Fig. 4A, toxin production of 630, 630∆erm or 630∆erm A+B- clustered 
together, as did toxin production of 630E, 630E A+B- or 630E A+B- CT with the latter three 
showing no statistical differences between them (P >0.05, one-way ANOVA with Fisher’s 
LSD test). There was, however, a statistically significant difference between the first three 
strains (630, 630∆erm or 630∆erm A+B-) and the second set of three strains (630E, 630E 
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A+B- or 630E A+B- CT) (P < 0.0001). The C. DIFFICILE TOX A/B II™ ELISA does not 
differentiate between toxin A and B. In order to be able to quantify each toxin, the kits 
from TGCbiomics were used (Fig. 4B and 4C). The toxin A ELISA showed significantly higher 
production in strain 630Δerm compared to 630E (p<0.0016) and also confirmed the 
previous observations that strains with impaired tcdB, produce more toxin A 8, 9 (Fig. 4B). 
No toxin B production was seen, as expected, in the tcdB-mutants. Strains 630 and 
630Δerm, however, both produced significantly more toxin B than 630E (p<0.0001) (Fig. 
4C). 
Whole genome sequencing 
To establish whether strains 630E and 630Δerm, and derivatives, contained any 
additional changes to the ermB gene deletion, relative to the parent strain 630, the 
following strains were sequenced using Next Generation Sequencing platforms: 630E A+B-, 
630E A+B- CT on Illumina HiSeq (GATC, Germany) and 630Δerm A-B on a Roche 454 
(Deepseq, University of Nottingham, UK) and the data compared to the published genome 
of the parental strain 630 12 and previously sequenced 630ΔermΔpyrE. 19 We used a 
frequency of 70% as a cut-off for SNP calling and found multiple SNPs, InDels and other 
minor changes, both common and unique to 630, 630E and 630Δerm. In total, two SNPs in 
coding regions with non-synonymous changes were found that were common to all three 
strains (in CD630_11900, encoding an acyl-CoA N-acyltransferase where SNP changes 
phenylalanine133 to leucine and in CD630_13880, a pseudo gene where a frameshift is 
introduced). In addition to these, we found in both 630 and 630Δerm strains three SNPs 
(two in intergenic regions and one in a coding region of CD630_2667, encoding the BC 
domain of a glucose PTS, changing valine228 to isoleucine). 630Δerm had seven unique 
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changes compared to 630 and 630E (including six non-synonymous SNPs in coding 
regions), while 630E had eleven SNPs (with nine non-synonymous SNPs in coding regions) 
not found in the other two strains. SNPs were confirmed by Sanger sequencing and 
thereafter by RNAseq data (see below). Indeed, the SNPs found in the DNA-seq data were 
validated by using the RNA-seq sequence reads mapped on the genome sequence with 
Bowtie2 20 with each position being checked using Tablet 21. A complete list of SNPs and 
other small changes are indicated in Table 1 and in supplementary Table S1. During the 
preparation of this manuscript a new sequence of 630 was published by Riedel et al. 22. We 
incorporated their data into Table 1 (and Table S1). Overall this new sequence shows very 
few disparities to the original one. However two SNPs found in our data were attributed to 
mistakes in the original sequence (in CD630_17670 and CD630_31561). Another paper was 
recently published by van Eijk et al., 23 resequencing 630Δerm. Overall there are very few 
discrepancies between their data and our findings, confirming the quality of both data sets. 
We have incorporated their findings into Table S1. 
It may be assumed, that during the repeated subculture of strain 630 undertaken in 
the Mullany 13 and Rood 14 laboratories, sub-populations within the culture were isolated 
carrying SNPs. However, it seems improbable that the two SNPs (Table 1), common to all 
three strains, arose independently. Rather we hypothesise that these SNPs might be 
sequencing mistakes. This theory gains weight through the new sequencing data by Riedel 
et al. 22. Two SNP changes which we identified originally between the published 630 
sequence and our data were confirmed by Riedel et al to also be the sequence of their 630 
seed stock. Unfortunately the genome announcement 22 does not state the exact source of 
their 630 strain. As mentioned above another three SNPs were only found in 630 and 
 10 
 
630Δerm, two of these are in intergenic regions which showed no expression in our 
RNAseq experiment, and the third is located in a PTS gene in 630 and 630Δerm (position 
3080703, Val228Ile). Rather than having occurred independently it is more likely that these 
SNPs arose in the Mullany laboratory, subsequent to provision of chromosomal DNA to the 
Sanger Centre for determination of the 630 genome sequence 12, and before the strain 630 
was passaged to obtain 630Δerm. At the time, C. difficile strains in the Mullany laboratory 
were routinely stored at 4°C as Robertson’s Cooked Meat stocks, as opposed to being 
frozen at -80°C in 10% glycerol (A.R. Roberts, personal communication). On this basis, the 
traditional microbiological practice of using Robertson’s Cooked Meat to curate strains 
might not be ideal as strains are not entirely dormant and genome changes can occur over 
time. The SNPs that were found to be unique to 630Δerm and 630E (n=8 and n=11, 
respectively) can be assumed to have been accrued at some point after the two 630 
populations diverged, that is when the strain was sent to the Rood laboratory. It is most 
likely, although not certain, that the majority, if not all of the strain-specific SNPs arose 
during the repeated subculture experiments undertaken to isolate the ermB deletion 
strains 630E and 630Δerm. 
Changes specific to 630Δerm include SNPs in three intergenic regions, which all have 
been determined with a coverage of over 150 and 100 % frequency (see Table 1). The 
other five changes comprise four non-synonymous SNPs and an insertion. The insertion 
has previously been reported by Rosenbusch et al.24 and was confirmed by van Eijk et al. 23 
and is an 18 bp duplication in spo0A, the master regulator of sporulation. This insertion 
might be responsible for the reduced sporulation frequency seen in strain 630 and also in 
630E and derivatives, which do not carry this duplication (which does not have this 
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duplication) (Fig. 3A). The SNPs have been found in the following genes: CD630_08260, 
encoding a ferric uptake regulator (perR homologue) (Thr41Ala); CD630_19070, encoding 
an alcohol dehydrogenase homologue (eutG) (Gly252Glu); and CD630_35630, encoding a 
transcriptional regulator of the GntR family (Ala91Val).  
In contrast, strain 630E contains a larger number of non-synonymous SNPs including 
changes that result in nonsense mutations and in one case the inversion of a small 
segment of DNA preceding a flagella operon. We found two changes in intergenic regions, 
one with 100 % frequency and a coverage of 94 (position 3528736); the other at a much 
lower frequency (41 %), but confirmed a 150 bp inversion by Sanger sequencing in the 
promoter region of flgB, the first gene in a F3 flagella operon (early flagella genes). Non-
synonymous SNPs were found in CD630_07610, encoding a putative RNA helicase 
(Asp136Tyr); CD630_14040, encoding an oligopeptide transporter (Glu536Gly); 
CD630_20270, encoding a hydrolase (Gly373Glu); CD630_29430, encoding a phage 
replication protein (Asn210Asp); and CD630_33790, encoding a conjugative transposon 
protein (Glu63Asp). Finally, there is another SNP at position 3034953, in gene CD630_26270 
(Gly68Cys), encoding a conserved hypothetical protein. Interestingly the new genome 
sequence from Eijk et al. 23 suggested an “A” at position 3034953 in contrast to the earlier 
annotation suggesting “C”. The new annotation is in line with our RNAseq data (Table S1) 
and taken into account our sequencing data (Table 1) suggests that this is indeed a 
mutation in 630E and was miss-annotated in the original sequence. In one instance the 
nucleotide substitution resulted in the creation of a nonsense, stop codon, and as a 
consequence a severe, premature truncation of the encoding protein. Thus, the stop codon 
introduced into CD630_12740 encoding a topoisomerase I (topA) homologue (Gln386*) 
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truncated the protein from 695 amino acids to 385 amino acids. Conversely, in the case of 
the glucose PTS operon ptsG-BC, the conversion of the stop codon of ptsG-B gene 
(CD630_26670) to a Glu codon (*524Glu) resulted in its fusion to the coding region of the 
immediately downstream ptsG-C gene.   
Virulence testing of 630Δerm, 630E and mutants using an in vivo model  
In order to confirm previous data and to rule out differences in experimental set up in 
different laboratories, the virulence of 630E and derivatives was assessed using the 
hamster infection model in our laboratory (University of Nottingham) as previously 
described. 9  
Figure 5 shows the times from infection to endpoint (in days) for the hamsters 
infected with 630E, 630E A+B- and 630E A+B- CT. For comparative purposes data for 
infection with 630Δerm and 630Δerm A+B- from a previous study 9 is also included.  The 
latter emphasises the fact that all eight hamsters infected with strain 630Δerm were 
colonised and succumbed to C. difficile disease (with an average time of 3.25 days from 
infection to endpoint). This is in direct contrast to what is observed with 630E where of the 
five animals successfully infected, only three were colonised till the respective endpoints 
and of these, two succumbed to disease (at day two and six). Two animals lost colonisation 
after days 15 and 18, respectively. 
In our previous study 9 seven, of the eight animals infected with 630∆erm A+B- (as also 
shown in Fig. 5), succumbed to disease with an average time to death of colonised 
hamsters being just under two days. One animal showed no signs of disease until the 
experimental endpoint, but was found not to have been colonised. Here of the 11 animals 
infected with the equivalent mutant of strain 630E (630E A+B-), only two animals 
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succumbed to CDI (on day two and nine). Four animals in this group were never colonised, 
one lost colonisation after day three and the others were colonised till endpoint. Six 
animals were infected with 630E A+B- CT, and of these two hamsters developed infection 
(day three and five). Two of the surviving animals lost colonisation after day 15 and 18 
respectively. (Fig. 5 and Table S2).    
The difference between the average time to death of all hamsters administered 
630∆erm and 630∆erm A+B- was found not to be statistically significant (one-way ANOVA, 
p=0.5355) (results from Kuehne et al. 9). Similarly, the differences between the average 
times to death of all animals administered 630E, 630E A+B- and 630E A+B- CT was not 
statistically significant (one-way ANOVA, p=0.8919). In contrast, the difference between 
the 630∆erm strain (and derivative) and the 630E strain (and derivatives) was statistically 
significant (one-way ANOVA, p>0.0001).   
Correction of SNPs in strain 630E 
In view of the large number of SNPs present in strain 630E, it was impractical to 
change them all back to the 630 parental sequence. We therefore selected just three 
specific mutations present in 630E and converted them back to the sequence present in 
the parental strain, 630.    
Our principal target was to remove the stop codon from within the topoisomerase I 
gene, CD630_12740, as this enzyme plays a central role in the regulation of DNA negative 
supercoiling and its inactivation is likely to result in extensive pleiotropic effects. Indeed, in 
some bacteria its inactivation is lethal. 25-27 Moreover, bacterial genes related to 
pathogenesis and virulence have been shown to be sensitive to topA mutation in E. coli, 28 
S. flexneri, 29 Yersinia enterocolitica 30 and Salmonella. 31 We therefore converted the “T” 
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nucleotide at position 1480649 in 630E back to an “A” nucleotide, thereby removing the 
nonsense stop codon and allowing the production of full length native topoisomerase 
enzyme.   
As a second target we elected to correct the inversion of DNA upstream of the F3 
flagella operon. As strain 630E is non-motile, and as the inverted region encompasses the 
non-coding region immediately upstream of the flgB gene, it is likely to have disrupted the 
promoter responsible for both flgB expression and the genes in the downstream operon. 
The inversion is therefore likely to be the principal cause of the loss of motility in 630E. 
Furthermore, factors affecting flagella expression can also influence toxin expression 
levels. 32, 33   
Finally, we sought to correct the fusion of the two PTS components ptsG-B and ptsG-C, 
by resurrection of the stop codon of ptsG-B through the conversion of the “C” nucleotide 
at position 3079815 back to an “A” nucleotide. As glucose is known to affect toxin 
production, through catabolite repression, 34, 35 it was reasoned that this particular SNP 
could be affecting toxin expression, and therefore virulence.  
The plasmids carrying the 630 wildtype alleles necessary for the correction of the 
three targeted SNPs were assembled as described in Materials and Methods and then used 
to effect the replacement of the 630E mutant alleles by allelic exchange. 15  To verify that 
the mutant clones obtained were correct, each targeted region was amplified by PCR using 
appropriate oligonucleotide primers and the DNA fragments obtained subjected to Sanger 
sequencing on both DNA strands. In every case, clones carrying the desired ‘corrected’ 
sequence were obtained. The new strains were named after the genes or regions that 
were corrected, namely 630E_topA, 630E_CD2667 and 630E_flgB, respectively.  
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To assess the effects of the changes on the characteristics of the mutant strains, 
growth rate, sporulation and germination, motility, and in vitro cytotoxicity and toxin 
production (ELISA) were measured. None of the three corrected mutants exhibited any 
difference in growth rate compared to the parental strain 630E (data not shown). Similarly, 
sporulation and germination remained unaffected (data not shown). Toxicity testing 
revealed no difference to 630E using the C. DIFFICILE TOX A/B II™ ELISA assay kit from 
TechLab (Fig. 4A). To quantify toxin A and toxin B individually the ELISA kits from 
TGCbiomics were used to assay 630E_topA and 630E_CD2667 (Fig. 4B). No differences 
were measured for toxin A, but the strain 630E_topA showed significantly higher levels of 
toxin B than the parental strain 630E. 
Transcriptomic comparison of 630, 630∆erm and 630E 
RNA was extracted from strains 630, 630∆erm and 630E at 6, 14 and 24 h and used in 
an RNAseq experiment as described in Materials and Methods. The Principal Component 
Analysis (PCA) (Fig. 6) showed that strain 630∆erm and 630E are closely correlated on a 
transcriptional level which is significantly separated from 630. While this result implies that 
both strains are fundamentally different to the parental strain, it does not indicate that the 
differences to 630 are the same for both strains. The analysis depicted by the Venn 
diagram (Fig. 7) confirms the results of the PCA, showing that the majority of differentially 
expressed genes are observed comparing 630∆erm and 630E to 630. From a total of 1337 
differentially expressed genes (Table S3 contains all the genes differentially expressed 
along the growth and also comparisons between the strains), only 139 were common 
between all three strains. A total of 345 were common between 630E and 630∆erm, 60 
were common between 630 and 630∆erm and 58 were common between 630 and 630E. 
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Most of the 345 genes differentially expressed in both, 630∆erm and 630E, were either 
up or down-regulated in the same way highlighting again how distinct the two strains are 
from the parental strain 630 (Table S3). In TY medium used for the transcriptomic 
experiments, known as a non-optimal for spore production, a total of 44 sporulation genes 
were differentially expressed in both 630∆erm and 630E, and all of these were 
downregulated at 14 and 24 h compared to 6 h. No further differentially expressed 
sporulation genes appeared in 630∆erm, however, our analysis showed a further 22 
sporulation genes, of which 21 were downregulated, in 630E. Amongst these was the 
master regulator of sporulation spo0A. Nine genes classed as stress-related are 
differentially expressed in all three strains (five upregulated), with a further three in 630 
(all upregulated), seven in 630∆erm (four upregulated) and 16 in 630E (11 upregulated). 
Nine genes related to secretion are down regulated in 630E and one gene related to type 
IV pili is upregulated. In comparison only one secretion gene (putative pilus assembly 
ATPase) is differentially expressed only in 630∆erm (down regulated) and none in 630. 
Metabolism is also highly differentially regulated in the three strains. 90 genes were 
uniquely, differentially expressed in 630E, 50 in 630∆erm and 30 in 630. In particular the 
amino acid metabolism stands out for 630E with the majority of genes being 
downregulated. (Table S3). 
RNAseq data can be used to independently corroborate genome re-sequencing data.  
Thus, it was apparent that those changes identified by CLC Bio as being present with a 
frequency of 70% or less, except for CD630_20102, were not real accordingly to the 
RNAseq analysis (Table S1). This increases the confidence in disregarding changes 
identified by NGS with a low frequency. In most cases, the SNPs and Indels identified by 
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NGS were confirmed by the RNAseq analysis, with the following exceptions: for SNPs in 
630E we found two disagreements notably in CD630_33790 and CD630_29430, which both 
had 100 % frequency and a high coverage (around 200 reads) in the DNA sequence 
analysis, but only low coverage in the RNAseq experiment.  Due to the low coverage of 
these regions during the RNAseq experiment, which is indicative of low or no expression 
under the examined conditions, a sequencing error cannot be excluded. For the SNP in 
CD630_12740 the RNA coverage corroborated the genomic data for 630E, but was in 
disagreement with the genomic data for 630 and 630∆erm. For three SNPs in 630∆erm 
similar scenarios were observed. CD630_19070 had very low RNA coverage, CD630_35650 
showed ambiguous RNA data with low coverage for 630E. CD630_08260, the perR 
homologue, had convincing DNA data, with frequencies of 98-100 % and coverage of at 
least a 100 which was corroborated for 630∆erm by RNAseq coverage.  
In terms of actual expression data (Table S1), CD630_07610 (the RNA helicase), 
CD630_14040 (oligopeptide transporter), CD630_20270 (hydrolase) and CD630_29430 
(phage replication protein) all showed differential expression in 630E compared to the 
other two strains, with the first two showing reduced expression and the latter two an 
increase.  CD630_29430, however, also showed an increase in expression in 630 at the 
later time point. Changes in CD630_26670 in 630∆erm and 630E both seem to lead to 
severely reduced expression. CD630_12740 (topA) only showed differential expression at 
24 h in 630∆erm and CD630_12140 (spo0A) expression was severely reduced in 630E. 
Discussion 
Previously, two studies 8,9 have attempted to use isogenic mutants defective in the 
production of either toxin A or toxin B to determine the relative importance of these two 
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virulence factors in CDI using the hamster infection model. However, despite generating 
essentially equivalent A+B-insertion mutants in ostensibly the same strain of C. difficile 
(630), contradictory outcomes were obtained in terms of the importance of toxin A. Thus, 
a tcdB mutant created in the one study 8 producing only TcdA did not cause disease in the 
hamster, whereas the equivalent ClosTron mutant made in our laboratory (Minton group) 9 
remained virulent. The work undertaken here has provided compelling evidence that the 
reason for the observed conundrum resides in the use of two different erythromycin-
sensitive derivatives of strain 630.  
Here we have shown that both erythromycin-sensitive derivatives, 630E 14 and 
630∆erm 13 carry a significant number of SNPs compared to the published sequence. 
Moreover, it is clear that whilst the phenotypic properties of 630∆erm and its mutant 
derivatives closely resemble that of the parent strain 630, strain 630E and its progeny 
exhibit substantive differences. Thus, whereas latter strains exhibit reduced growth rates, 
are less proficient in spore formation and are non-motile, 630∆erm strains mirror the 
behaviour of the 630 parental strain with respect to these phenotypes. Furthermore, 630E 
strains produce reduced amounts of toxin and both struggle to colonise hamsters, and 
once colonised, animals are less likely to succumb to disease. In short, 630E and its 
derivatives (i.e., 630E A-B+ and 630E A+B- CT) are less virulent than 630∆erm and its 
mutant counterparts (i.e., 630∆erm A+B-).    
The altered properties of 630E and its derivatives are undoubtedly a consequence of 
the observed SNPs. However, the substantive number of changes involved makes it 
difficult to assign any particular SNP to a specific alteration in the observed phenotype, 
particularly as a combination of mutagenic changes could be responsible. Whilst it is now 
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possible to make precise changes to the genome using allelic exchange methodologies 15 it 
is not practically feasible to make all of the sequential rational changes needed to 
definitively identify the mutation(s) responsible for a particular phenotype. As such, we 
only corrected three specific SNPs that we reasoned may be making a significant 
contribution. The outcomes of these experiments only emphasised the difficulty of such an 
undertaking, and served to highlight the dangers involved in making assumptions. Thus, 
whilst it seemed reasonable to assume that the DNA inversion within the promoter region 
of the flagella operon was likely to have caused the observed non-motile phenotype, this 
surprisingly proved not to be the case. Re-inversion of the 150 bp region failed to restore 
motility. Clearly other SNPs are at least partly responsible for the observed lack of motility. 
Singling out any other SNP as the culprit would in the absence of experimental evidence be 
counterproductive. 
Equally negative was the observed outcome of correcting the mutation in 
CD630_12740 that results in a truncation of the encoded topoisomerase I enzyme. Given 
this enzyme controls DNA supercoiling, and given that its mutation in certain bacteria is 
either a lethal event 25-27 and/or is involved in the regulation of virulence factors, 28-30 it 
seemed likely that its presence would result in pleiotropic effects that could have 
contributed to the observed phenotypic changes. However, its correction, with the 
exception of a measurable increase in toxin B levels, seemingly had no effects on the 
behaviour of the strain, at least for those properties measured. The reasons are not clear. 
In other bacteria, mutations of topA are only isolated if compensatory mutations arise 
elsewhere in the genome. 26  Whether any of the other SNPs present in 630E (eg., the RNA 
helicase mutation) are negating the effects of the TopA truncation is currently unknown.   
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To understand the differences observed further, we analysed the transcriptome of 
630, 630∆erm and 630E, comparing expression at 6 h to 14 h and to 24 h (Table S3). The 
data corroborated the phenotypic analysis, showing vastly different transcriptomes for all 
three strains. While 630E and 630∆erm cluster together in the PCA (Fig. 6), this only 
highlights how different the two strains really are from the progenitor. The analysis clearly 
shows that the three strains are very different from each other and also serves as an 
explanation as to why the change of a single SNP could not restore any given phenotype. 
Overall 630E seems the most divergent with many genes differentially expressed involved 
in metabolism and regulation (Table S3). Additionally 32 genes grouped under the 
descriptor ‘cell factor’, many of which play a role in energy metabolism, are differentially 
expressed in 630E, with only six of these being upregulated. In contrast out of 19 genes in 
630, 11 are upregulated and, out of 10 in 630∆erm, six were upregulated. The number of 
genes downregulated in energy metabolism in 630E might relate to the growth differences 
seen between the strains.  
Interestingly 22 genes involved in sporulation are differentially expressed, 21 of these 
downregulated, in 630E versus one in 630 and two in 630∆erm. This is consistent with the 
observed delay in sporulation and reduced amount of spores produced by 630E. Secretion 
also seems most affected in 630E, with 10 genes differentially expressed, compared to 
none in 630 and one in 630∆erm.  A general defect in secretion could affect the secretion 
of certain virulence or adhesion factors. Furthermore, 33 cell wall genes are differentially 
expressed in 630E (compared to 14 each in 630∆erm and 630). This may also contribute to 
the observed colonisation deficiencies. Mobile elements are, however, more differentially 
transcribed in 630 and 630∆erm (15 each) versus 630E (nine). As in many cases different 
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pathways were affected, we propose that this could at least in part explain the different 
adaptability and virulence of the two strains. In both strains many regulators were 
differentially affected providing a further basis for the observed phenotypic variation 
between strains. 
Conclusion 
Our study has established that the parental strains (630E and 630∆erm) used in the 
two previous studies, that explored the relative roles of toxin A and toxin B in disease, 8, 9 
are phenotypically and genetically distinct. Here we also reveal that the three strains (630, 
630∆erm and 630E) have vastly different transcriptomes, which no doubt lead to the 
different phenotypes observed. This immense diversity also underlines our finding that by 
restoring just one SNP, the entire transcriptome cannot be changed. The presence of SNPs 
in strain 630E significantly affects its transcriptome which in turn has a significant impact 
on growth, sporulation and finally virulence of this strain in the hamster model of infection 
under the conditions tested. Data (such as motility, toxicity and virulence) obtained with 
strain 630∆erm reflects more accurately the behaviour of the parent strain 630. As such, it 
may be concluded that 630 producing toxin A alone will cause disease in the hamster. As a 
consequence, toxin A should remain a target for the rational development of effective 
countermeasures against C. difficile.   
This study has also highlighted a number of issues that need to be borne in mind in the 
future. At a specific level, if researchers wish to undertake genetic-based studies with 
strain 630, then the use of strain 630∆erm should be favoured over strain 630E. At a more 
fundamental level, researchers need to effectively curate their strains to prevent the 
inadvertent isolation of SNPs. Ideally, master seed banks need to be established as frozen 
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glycerol stocks. Moreover, the genome of the stored strain should be re-sequenced as part 
of the storage process whenever a strain is received from external sources, regardless of 
whether it has been re-sequenced in the sending laboratory.  
Materials and Methods 
Bacterial strains and routine culture conditions 
Bacterial strains and plasmids used in this study are listed in Table 2. E. coli was 
cultured aerobically at 37°C with shaking at 200 rpm in LB medium with chloramphenicol 
supplementation (25 μg/ml) where appropriate. C. difficile was cultured in TY (tryptose 
yeast) medium supplemented with thiamphenicol (15 μg/ml) where appropriate. When 
needed, C. difficile strains were plated on BHIS agar (Brain Heart Infusion agar [Oxoid] 
supplemented with 5 mg/ml yeast extract [Oxoid] and 0.1% [wt/vol] cysteine 
[Calbiochem]) supplemented with d-cycloserine (250 μg/ml), cefoxitin (8 μg/ml) [Oxoid] 
(BHIScc). Fluorocytosine selections were carried out on C. difficile minimal medium 
(CDMM) as described previously.  15 All C. difficile cultures were incubated at 37°C 
anaerobically in an anaerobic MACS1000 workstation (Don Whitley, Yorkshire, UK).  
Mutant nomenclature 
For the sake of simplicity, C. difficile strains that carried a tcdA insertional mutant were 
referred to as A-, those carrying a tcdB mutant as B-, and those strains carrying a mutation 
in both genes as A-B-. To avoid any ambiguity, if the gene was not inactivated it was 
referred to as A+ or B+, as appropriate. Thus, a tcdA mutant of 630Δerm constructed using 
ClosTron technology as described, 9, 16 was designated 630Δerm A-B+. The equivalent 
mutant in 630E constructed through the insertion of a replication-deficient plasmid, 
according to the method of O’Connor et al., 14 was designated 630E A-B+. When ClosTron 
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technology was used in 630E, this was clarified by adding a ‘CT’ suffix, 630E A-B+CT to the 
strain designation. 
Whole genome sequencing and bioinformatics 
Genomic DNA from strains 630E A+B-, 630E A+B-CT and 630Δerm A+B- was prepared 
by phenol:chloroform extraction. 630E A+B-, 630E A+B-CT, 630Δerm(ΔpyrE) were 
sequenced on Ilumina highseq (GATC, Germany) and 630Δerm A+B- on a Roche 454 
(Deepseq, Nottingham, UK) and the data compared to the published genome of 630 11,19 
using CLC genomic workbench. All raw sequencing data have been deposited in the 
sequence read archive (SRA) under the study name PRJNA304508. The accession number is 
SRP066836. The sequencing data for 630ΔermΔpyrE had been obtained previously 19 and 
with no additional changes, other than the pyrE deletion, present compared to 630Δerm, 
were used to analyse the parental strain 630Δerm. We used a frequency of 70% as a cut-off 
for SNP calling. SNPs, InDels and inversions were confirmed by amplifying a few hundred 
base pairs up- and downstream of the area of interest (primers are listed in Table S4) and 
the amplicon was Sanger sequenced (Source BioScience, UK). This confirmation was done 
on all strains including the parental strains (630, 630Δerm, 630E) and the derivatives 
(630Δerm A+B-, 630E A+B-, 630E A+B-CT). 
Correction of SNPs and reversal of 150-bp region within the flagellar operon 
Using the method described by Cartman et al. 15 we “corrected” the two SNPs and an 
inversion in 630E to the 630Δerm genotype. A stretch of DNA corresponding to 
approximately 500 bp either side of the area to be altered was synthesised by Biomatik 
and cloned into plasmid pMTL-SC7315λ2.3. This vector was transformed by 
electroporation into E. coli CA434 cells 36 and subsequently conjugated into 630E. Single 
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crossover colonies were identified as those growing faster on plates containing 
thiamphenicol. Following overnight incubation on CDMM containing 5-fluorocytosine, 
colonies were incubated on BHIScc plates with and without thiamphenicol. Those strains 
that had lost the plasmid (both wildtype and double crossover) were unable to grow on 
thiamphenicol. SNP corrections were confirmed by PCR (Primers see Table S4) and Sanger 
sequencing (Source BioScience, UK).   
ClosTron mutagenesis 
A tcdB mutant was generated in the 630E background according to the published 
method, 16 using the same plasmid that was used to generate the equivalent mutant in 
630∆erm.  9  This newly created strain was referred to as 630E A+B- CT.  
Southern and Western blot 
The Southern and Western blot were performed as described in Kuehne et al., 2010. 9 
In vivo testing of mutants 
In vivo testing was carried out in Syrian Golden hamsters (Charles River, Germany) as 
previously described. 9 Briefly, clindamycin was administered orally on day -five to render 
the animals susceptible to infection. On day zero, 10,000 spores were administered orally. 
Animals were assessed for signs of CDI (weight loss, wet tail, lethargy, lack of response to 
stimulus) six times a day for the first five days, and once daily for the following 14 days. At 
this point animals that failed to display signs of CDI were euthanised.  Faecal pellets were 
collected daily from day zero to endpoint, homogenised and plated on C. difficile fructose 
agar (CDFA). C. difficile colonies were sub-cultured onto BHIS agar and the genotype was 
established by PCR (primers in Table S4) followed by Sanger sequencing (results in Table 
S2).  At the experimental endpoint, part of the caecum of each animal was collected. This 
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was also used to plate on CDFA to verify colonisation.   
In vitro testing of mutants 
Growth curves 
To assess the effects of SNPs and “corrected” SNPs/inversion on the growth characteristics 
of all strains, we performed growth curve experiments over 24 h. A 180 μL volume of TY 
medium was inoculated with 20 μL of an overnight culture in 96-well plates and incubated 
for 24 h in a GloMax-Multi Microplate Multimode Reader (Promega, USA). Samples were 
shaken every h and OD600 measurements were taken immediately after.   
Motility assays 
2xYTG (tryptone (1.6%), yeast (1%), NaCl (0.4%), Gelzan (0.24%)[Sigma-Aldrich] and 
glucose (0.5%)) agar was utilised. 25 mL were poured into each petri dish and let to solidify 
at room temperature for 15 min. The plates were then dried at 37°C for 30 min. The plates 
were placed into the anaerobic cabinet 24 h before use. 2 μL volumes of overnight culture 
were ‘dropped’ onto each plate. Plates were incubated anaerobically for 48 h. Motility was 
assessed by eye and the plates photographed.  
Sporulation and germination assays 
Sporulation and germination assays were carried out as previously described. 17, 18  Briefly, 
for the sporulation assay cultures were grown for five days, with 2 X 500 µl samples taken 
at 0, 24, 48, 72, 96 and 120 h. One sample from each time point was heated to 65°C for 30 
min while the other sample was kept at room temperature. After this time, samples were 
serially diluted from 100 to 10-7 in PBS. 3 X 20µl of each dilution was spotted onto BHIS 
plates containing 0.1% taurocholic acid and were incubated for 24 h. The following day, 
colonies were counted and CFU/mL were calculated. A 630∆erm spo0A::CT mutant strain 
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(containing a ClosTron insertion in the spo0A gene 37), which is unable to form spores, was 
used as a negative control.  
Germination was measured as a function of the ability of a germinated spore to 
outgrow in the absence of taurocholate. Spore stocks were prepared as previously 
described by Heeg et al., 2012 38 and stored at -20°C. The optical density of spore 
suspensions (OD600) was adjusted to 1.0 and 450 µl was used per measurement. This 
equated to approximately 2.5 X 107 spores. Spore suspensions were heat treated at 60°C 
for 25 min to kill any remaining vegetative cells and then centrifuged and resuspended in 
BHIS with the germinant taurocholic acid (0.1%) in a total volume of 20 ml. Samples were 
taken at 5, 10, 20, 30, 60, 90, 120, 180 and 240 min, briefly centrifuged, washed and 
resuspended in phosphate-buffered saline (PBS), the samples were then diluted and plated 
on plain BHIS agar. Plates were incubated for 24 h before the CFUs were enumerated.  
Colonies that grew on these plates were considered to be germinated vegetative bacteria.   
Toxin A/B ELISA 
ELISA assays were performed using the C. DIFFICILE TOX A/B II™ kit from TechLab and the 
TGC-E002-1-separate detection of C. difficile toxins A and B kit from TGCbiomics according 
to the manufacturers’ instructions. Cultures of C. difficile were grown in TY medium 
without glucose for 72 h, at which time 1 ml samples were taken, centrifuged and the 
supernatant filter-sterilised and used for the ELISAs. A 1:2 dilution was used for the toxin B 
ELISA kit from TGCbiomics.  To quantify toxins a standard curve with pure toxin (the native 
antigen company) was established for the TechLab ELISA and also Toxin A ELISA from 
TGCbiomics. 
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RNAseq 
Total RNA was extracted from 2 independent biological replicates of 630, 630∆erm and 
630E strains at 3 time points (18 samples). Bacteria were grown in TY broth medium after 
6, 14 and 24 h as previously described. 35  The mRNA was treated with MicrobExpress kit 
(Ambion). For oriented RNA-seq library construction, the Truseq stranded RNA seq Illumina 
kit was used according to manufacturer’s instructions before sequencing using the Illumina 
HiSeq 2500 machine. Sequencing reads were mapped using Bowtie 39 to the reannotated 
630 reference genome 40 complemented with the known ncRNA. 41  Statistical analyses 
were performed on each strand coverage count with DESeq2 42 using the 6 h value as a 
reference for reporting the expression data of 14 and 24 h. A gene was considered 
differentially expressed when the fold change was > 2 and the P value was < 0.05. 
The RNA-seq data discussed in this publication have been deposited in NCBI’s Gene 
Expression Omnibus database under the accession no. GSE72006  
RNA-seq coverage visualization is available through the COV2HTML software: 43  
630 
14H - 6H http://mmonot.eu/COV2HTML/visualisation.php?str_id=-20 
24H - 6H http://mmonot.eu/COV2HTML/visualisation.php?str_id=-22 
630∆erm 
14H - 6H http://mmonot.eu/COV2HTML/visualisation.php?str_id=-24 
24H - 6H http://mmonot.eu/COV2HTML/visualisation.php?str_id=-26 
630E 
14H - 6H http://mmonot.eu/COV2HTML/visualisation.php?str_id=-28 
24H - 6H http://mmonot.eu/COV2HTML/visualisation.php?str_id=-30 
Graphs and statistical analyses 
All graphs were generated and statistical analyses were performed using GraphPad 
PRISM 6.02. Statistical analysis comprised either 2-way ANOVA for multiple comparisons or 
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unpaired t test for pairwise comparisons. All experiments were carried out in triplicate 
unless stated otherwise. 
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Table 1. Single Nucleotide Polymorphisms (SNPs) and other changes found after re-sequencing.  
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The table shows the Single Nucleotide Polymorphism (SNP) changes in 630∆erm and 630E 
compared to the reference 630 12 and also the new annotation by Riedel et al (The column ‘Gene’ 
represents the gene (or intergenic region (IG)) in which the change occurs, the column ‘position’ 
indicates the exact nucleotide position of the change.). 22 It also contains SNP frequency (F) and 
genomic coverage (C) as well as the resultant amino acid change (AA). No change from the original 
630 annotation 12 is represented by a dash (-).  
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Table 2.  Strains and plasmids used in this study. 
Name Description Source 
Bacterial strains 
E. coli TOP 10 F– mcrA Δ(mrr-hsdRMS-mcrBC) 
Φ80lacZΔM15 ΔlacX74 recA1 araD139 Δ (ara 
leu) 7697 galU galK rpsL (Str
R
) endA1 nupG 
Invitrogen 
E. coli CA434 Conjugation donor Williams et al. 
36
 
C. difficile 630 Wild-type Brendan Wren 
C. difficile 630Δerm Erythromycin sensitive strain of C. difficile 630 Hussain et al. 
13
 
C. difficile 
630Δerm(ΔpyrE) 
C. difficile 630Δerm containing a deletion in 
the pyrE gene 
Ng et al.
 19
 
C. difficile 630E Erythromycin sensitive strain of C. difficile 630 Lyras et al. 
8
 
C. difficile 630Δerm 
A+B- 
C. difficile 630∆erm tcdB-1511a::intron ermB Kuehne et al. 
9
 
C. difficile 630E A+B- C. difficile 630E Lyras et al. 
8
 
C. difficile 630E A+B-
CT 
C. difficile 630E tcdB-1511a:: intron ermB This study 
C. difficile 630E_topA C. difficile 630E This study 
C. difficile 630E_flgB C. difficile 630E This study 
C. difficile 
630E_CD2667 
C. difficile 630E This study 
Plasmids   
pMTL007C-E2:tcdB-
1511a 
ClosTron plasmid containing retargeted region 
to tcdB at IS 1511 (antisense oriented) for C. 
difficile 630∆erm or 630E 
Kuehne et al. 
9
 
pMTL- pMTL-SC7315λ2.3 containing 1,000 bp 
homology arms to change nucleotide 1480649 
This study, based on 
 35 
 
SC7315λ2.3::topA from T to C in 630E Cartman et al. 
15
 
pMTL-
SC7315λ2.3::flgB 
pMTL-SC7315λ2.3 containing 1,156 bp 
homology arms to reverse the inversion 
upstream of flgB in 630E 
This study, based on 
Cartman et al. 
15
 
pMTL-
SC7315λ2.3::CD2667 
pMTL-SC7315λ2.3 containing 1,000 bp 
homology arms to change nucleotide 3079815 
from C to A in 630E 
This study, based on 
Cartman et al. 
15
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Figure 1.  Growth curves of strain 630 and its derivatives. A. 630 (630), 630Δerm and 630E were 
grown in TY-broth for 24 h in a 96 well plate reader. The optical density at 600 nm was measured 
every 30 min. B. This graph shows the same growth as A. and in addition the growth of derivatives 
630Δerm A+B-, 630E A+B- and 630E A+B- CT. 
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Figure 2.  Motility assays. The assay was carried out by inoculating overnight cultures onto motility 
agar plates and incubating anaerobically for 48 h. Strains 630, 630∆erm and 630E were compared 
for their ability to swarm. 
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Figure 3.  Sporulation and Germination.  A. Sporulation over 120 h comparing heat treated CFUs of 
strains 630, 630∆erm, 630∆erm A+B-, 630E, 630E A+B- and 630E A+B- CT with a non-sporulating 
control (spo0A). B. The extent of germination of the indicated strains was measured over 250 min 
as the ability of germinated spores to form colonies on plates lacking taurocholate.    
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Figure 4.  Toxin ELISAs. A. The C. DIFFICILE TOX A/B II™ ELISA assay kit from TechLab was used to 
measure combined toxin A and B in strains 630, 630∆erm, 630∆erm A+B-, 630E, 630E A+B-, 630E 
A+B- CT, 630E_topA, 630E_flgB and 630E_CD2667 grown in TY for 72 h. B. and C. Toxin ELISAs 
TGCbiomics, measuring the toxins separately were used to quantify toxin A (B) and toxin B (C) 
produced by strains 630, 630∆erm, 630∆erm A+B-, 630E, 630E A+B- and 630E A+B- CT grown in TY 
for 72 h. Statistics were performed using one-way ANOVA with Fisher’s LSD test. 
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Figure 5.  Infection to endpoint in the Hamster infection model.  Groups of Golden Syrian Hamsters 
were challenged with C. difficile 630E (5 hamsters), 630E A+B- (11 hamsters) and 630E A+B- CT (6 
hamsters). The graph represents the time from inoculation to endpoint. The maximal duration of 
the experiment was set to 20 days. Animals represented in open symbols, have not been colonized 
despite challenge or lost colonization before day 20. Details can be seen in Table 1. The dotted line 
separates this experiment from data obtained by Kuehne et al. 
9
, which are represented here as a 
comparator. In that study 8 hamsters were infected with C. difficile 630Δerm and another 8 
hamsters with 630Δerm A+B-. 
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Figure 6. Principal Component Analysis (PCA).  The Principal Component Analysis (PCA) visualizes 
the variance of the data in a single graph. The axis represent the two largest variances of the data; 
PC1 accounts for 42% and PC2 accounts for 21%, that means that 63% of the total variance of the 
dataset is explained in this graph. The third component accounts for less than 10% and further 
components have a value that falls rapidly. The PCA represents the RNAseq data (at three different 
time points, six, 14 and 24 h) in duplicate for 630 (blue), 630Δerm (green) and 630E (orange). The 
different time points are represented as dots in the different shades of the respective colour as 
indicated in the colour legend. 
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Figure 7. Venn Diagram representing differentially expressed genes in the three different strains. 
The diagram summarises the output from the RNAseq data, comparing strains 630, 630Δerm and 
630E. It depicts all differentially expressed genes and shows how many genes are differentially 
expressed in all strains, in two of the strains or are unique to just one strain.  
 
